drugset / Trial / NCT01165866

Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis

NCT01165866 ↗

Phase 4 Completed 170 enrolled Hamad Medical Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Is intravenous metoclopramid as effective as intravenous ondansetron in the treatment of persistent vomiting in patients with acute gastroenteritis.

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Outcome

Missed primary endpoint

paper Cessation of vomiting was achieved in 68/84 patients (81%) of the ondansetron and 60/83 (72%) of the metoclopramide groups, P = 0.14. PMID 21788756 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 0.3 mg/kg Intravenous
Subject Ondansetron Other / unclassified 0.15 mg/kg Intravenous

Indications